Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Neuron

• Publication date

  2010-12-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neuron.2010.11.030PMID 21172610PMCID PMC3026458
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural and functional changes in tau mutant mice neurons are not linked to the presence of NFTs.

  2010influential reference
• Aβ Oligomers Cause Localized Ca2+ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines

  2010cited by this paper
• Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models.

  2010cited by this paper
• Excitatory amino acid involvement in dendritic spine formation, maintenance and remodelling

  2010cited by this paper
• The pattern of human tau phosphorylation is the result of priming and feedback events in primary hippocampal neurons.

  2010cited by this paper
• ZnT3 mRNA levels are reduced in Alzheimer's disease post-mortem brain

  2009influential reference
• Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings.

  2009cited by this paper
• Reversal of long-term dendritic spine alterations in Alzheimer disease models

  2009influential reference
• The proline-rich domain of tau plays a role in interactions with actin

  2009cited by this paper
• Dynamic microtubules regulate dendritic spine morphology and synaptic plasticity.

  2009influential reference
• Divergent Pathways Mediate Spine Alterations and Cell Death Induced by Amyloid-β, Wild-Type Tau, and R406W Tau

  2009cited by this paper
• The role of tau in neurodegeneration

  2009cited by this paper
• Age-Dependent Impairment of Cognitive and Synaptic Function in the htau Mouse Model of Tau Pathology

  2009cited by this paper
• Activity-Dependent Dynamic Microtubule Invasion of Dendritic Spines

  2008influential reference
• Differential Regulation of Dynein and Kinesin Motor Proteins by Tau

  2008cited by this paper
• Dendritic Spine Loss and Synaptic Alterations in Alzheimer’s Disease

  2008cited by this paper
• Glutamate receptor dynamics in dendritic microdomains.

  2008cited by this paper
• Microtubules in Dendritic Spine Development

  2008influential reference
• Independent Expression of Synaptic and Morphological Plasticity Associated with Long-Term Depression

  2007cited by this paper
• Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies.

  2007cited by this paper
• Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo

  2007influential reference
• Earliest Stages of Tau Conformational Changes are Related to the Appearance of a Sequence of Specific Phospho-Dependent Tau Epitopes in Alzheimer's Disease

  2007cited by this paper
• Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model.

  2007influential reference
• Tau phosphorylation sites work in concert to promote neurotoxicity in vivo.

  2007cited by this paper
• Dendritic Pathology in Prion Disease Starts at the Synaptic Spine

  2007cited by this paper
• The β-Propensity of Tau Determines Aggregation and Synaptic Loss in Inducible Mouse Models of Tauopathy*

  2007cited by this paper
• Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation).

  2007cited by this paper
• S/P and T/P phosphorylation is critical for tau neurotoxicity in Drosophila

  2007influential reference
• Double dissociation between long-term depression and dendritic spine morphology in cerebellar Purkinje cells

  2007cited by this paper
• Presynaptic α-Synuclein Aggregates, Not Lewy Bodies, Cause Neurodegeneration in Dementia with Lewy Bodies

  2007cited by this paper
• Improved Long-Term Potentiation and Memory in Young Tau-P301L Transgenic Mice before Onset of Hyperphosphorylation and Tauopathy

  2006cited by this paper
• Relative and Absolute Quantification of Postsynaptic Density Proteome Isolated from Rat Forebrain and Cerebellum*S

  2006cited by this paper
• Tau Aggregation and Progressive Neuronal Degeneration in the Absence of Changes in Spine Density and Morphology after Targeted Expression of Alzheimer's Disease-Relevant Tau Constructs in Organotypic Hippocampal Slices

  2006cited by this paper
• Non‐fibrillar β‐amyloid abates spike‐timing‐dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors

  2006cited by this paper
• Reduction of Soluble Aβ and Tau, but Not Soluble Aβ Alone, Ameliorates Cognitive Decline in Transgenic Mice with Plaques and Tangles*

  2006cited by this paper
• Glutamate induces the rapid formation of spine head protrusions in hippocampal slice cultures

  2005cited by this paper
• Post-translational modifications of tau protein in Alzheimer’s disease

  2005cited by this paper
• Infectious disease: Unravelling SARS lethality

  2005cited by this paper
• Tau alteration and neuronal degeneration in tauopathies: mechanisms and models.

  2005influential reference
• Mu-opioid receptors modulate the stability of dendritic spines.

  2005cited by this paper
• Age-Dependent Neurofibrillary Tangle Formation, Neuron Loss, and Memory Impairment in a Mouse Model of Human Tauopathy (P301L)

  2005influential reference
• Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function

  2005influential reference
• Role of tau protein in both physiological and pathological conditions.

  2004influential reference
• Arp2/3 is a negative regulator of growth cone translocation.

  2004cited by this paper
• Temporal dynamics of NMDA receptor-induced changes in spine morphology and AMPA receptor recruitment to spines.

  2004cited by this paper
• Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses.

  2003cited by this paper
• Phosphorylated serine 199 of microtubule-associated protein tau is a neuronal epitope abundantly expressed in youth and an early marker of tau pathology

  2003influential reference
• The Relationship between Aβ and Memory in the Tg2576 Mouse Model of Alzheimer's Disease

  2002influential reference
• The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease.

  2002influential reference
• Alzheimer's Disease Is a Synaptic Failure

  2002influential reference
• AMPA receptor trafficking and synaptic plasticity.

  2002cited by this paper
• Extended analysis of path data from mutant mice using the public domain software Wintrack.

  2001influential reference
• Altered expression of synaptic proteins occurs early during progression of Alzheimer’s disease

  2001cited by this paper
• Dentritic spines : structure, dynamics and regulation

  2001influential reference
• Tau protein isoforms, phosphorylation and role in neurodegenerative disorders.

  2000influential reference
• Glutamate receptors regulate actin-based plasticity in dendritic spines

  2000cited by this paper
• Miniature synaptic events maintain dendritic spines via AMPA receptor activation

  1999cited by this paper
• Regulation of morphological postsynaptic silent synapses in developing hippocampal neurons

  1999influential reference
• Evidence for silent synapses: implications for the expression of LTP.

  1995influential reference
• Activation of postsynaptically silent synapses during pairing-induced LTP in CA1 region of hippocampal slice

  1995cited by this paper
• Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

  1991cited by this paper
• Phosphorylation determines two distinct species of Tau in the central nervous system.

  1987cited by this paper
• A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease.

  1987influential reference
• Cytoplasmic actin in neuronal processes as a possible mediator of synaptic plasticity

  1982influential reference

• Phytomicronutrients in neurodegeneration: modulating microglial dynamics for neuroprotection

  2026cites this paper
• Neuromechanobiology: Bridging Mechanobiology and Neuroscience Through Evidence and Open Questions

  2026cites this paper
• Implications of virus-induced stress granules in tauopathies

  2026cites this paper
• Targeting tau in Alzheimer's Disease: rationale, approach and challenges.

  2026cites this paper
• R5 and R7 positions on fluoroquinolone scaffolds drive F-actin filament disruption.

  2026cites this paper
• Molecular sabotage of hippocampal synaptic plasticity by amyloid-β in Alzheimer's disease: A narrative review

  2026cites this paper
• Regional correlates of tau pathology and synaptic function in primary age-related tauopathy.

  2026cites this paper
• Distinct mechanistic pathways of early tauopathy revealed by MAPT mutations

  2026cites this paper
• Spilling the T: T cells in tauopathy mechanisms, disease progression, and therapeutic horizons

  2026cites this paper
• Tau in Alzheimer's disease: Shaping the future patient journey

  2026cites this paper
• Selective vulnerability of human synapses to soluble tau oligomers.

  2026cites this paper
• Exercise training mitigates age-related cognitive decline by attenuating TMAO-induced inflammation

  2026cites this paper
• Prediction of longitudinal synaptic loss in Alzheimer's disease using tau PET and plasma biomarkers

  2025cites this paper
• Carbon nanomaterials for tau targeting in Alzheimer's disease: Theranostic strategies and clinical prospects

  2025cites this paper
• The Direction and Future of Alzheimer’s Treatment

  2025cites this paper
• GSK-3β dysregulation in aging: Implications for tau pathology and Alzheimer's disease progression.

  2025cites this paper
• Diverse influences on tau aggregation and implications for disease progression

  2025cites this paper
• PP2A methylesterase, PME‐1, and PP2A methyltransferase, LCMT‐1, control sensitivity to impairments caused by injury‐related oligomeric tau

  2025cites this paper
• Ligature-induced periodontitis in a transgenic mouse model of Alzheimer's disease dysregulates neuroinflammation, exacerbates cognitive impairment, and accelerates amyloid pathology

  2025cites this paper
• A Massively Parallel CRISPR-Based Screening Platform for Modifiers of Neuronal Activity

  2025cites this paper
• Tau protein: Physiological functions and multifaceted roles in neurodegenerative and psychiatric disorders.

  2025cites this paper
• Neuropathological Research Developed From the Analysis of Forensic Autopsy Cases

  2025cites this paper
• Targeted tau protein degradation: a promising therapeutic approach for tauopathies.

  2025cites this paper
• Fast Interneuron Dysfunction in Laminar Neural Mass Model Reproduces Alzheimer's Oscillatory Biomarkers

  2025cites this paper
• RILP Cleavage Links an Inflammatory State to Enhanced Tau Propagation in a Cell Culture Model of Alzheimer's Disease.

  2025cites this paper
• Ser14-phosphorylated Rpn6 Limits Proteostasis Impairment and Pathology in Both Brain and Heart of Tauopathy Mice

  2025cites this paper
• Elevated TGF-β1 impairs synaptic and cognitive function through activation of Smad2/3-Sp1 pathway in AngII-related hypertension

  2025cites this paper
• Differential roles of human tau isoforms in the modulation of inflammation and development of neuropathology

  2025cites this paper
• Ultrasmall Nanoparticles Mitigate Tau Hyperphosphorylation to Restore Synaptic Integrity and Boost Cognitive Function in Alzheimer's Disease

  2025cites this paper
• Alzheimer's Disease and Frontotemporal Dementia: A Review of Pathophysiology and Therapeutic Approaches

  2025cites this paper
• The interplay between age at menopause and synaptic integrity on Alzheimer’s disease risk in women

  2025cites this paper
• Graded regulation of microtubule-binding of Tau by the phosphorylation state of the proline-rich region in living neurons

  2025cites this paper
• Therapeutic Potential of Leptin in Neurodegenerative Disease

  2025cites this paper
• Tau deletion results in sex-dependent modulation of synaptic weakening in rat hippocampus

  2025cites this paper
• rTg4510 Tauopathy Mice Exhibit Non-Spatial Memory Deficits Prevented by Doxycycline Treatment

  2025cites this paper
• A disubstituted aniline probe for enhanced peroxidase-based proximal protein labelling

  2025cites this paper
• Low synaptic and neurosecretory proteins in cerebrospinal fluid in early parkinsonian disease.

  2025cites this paper
• Pathological and Functional Brain Amyloids: A New Concept Explaining the Differences

  2025cites this paper
• Light-Inducible Deformation of Mitochondria in Live Cells.

  2025cites this paper
• Pathological tau alters head direction signaling and induces spatial disorientation.

  2025cites this paper
• Individual-neuron optical brain stimulation (iOBS) alleviates behaviors in an Alzheimer's disease mouse model

  2025cites this paper
• DAP12 deletion reduces neuronal SLIT2 and demyelination and enhances brain resilience in female tauopathy mice

  2025cites this paper
• Retinal tau phosphorylation in Alzheimer’s disease: a mass spectrometry study

  2025cites this paper
• Cholestanol promotes tau pathology in a mouse model of tauopathy

  2025cites this paper
• Synaptic Dysfunction in Alzheimer’s Disease: A Narrative Review of Neuronal Changes

  2025cites this paper
• Apolipoprotein E gene allele 4 and amyloid-beta mediate tau-related network breakdown

  2025cites this paper
• Traumatic brain injury and Alzheimer's disease related neurodegenerative diseases: Insights from animal models.

  2025cites this paper
• Integrating neuroinflammation biomarkers into the ATN(X) framework: Advances in Alzheimer's pathogenesis, diagnosis, and insights from non‐human primate models

  2025cites this paper
• NMDA receptors in neurodegenerative diseases: mechanisms and emerging therapeutic strategies

  2025cites this paper
• Neuroplasticity and brain health: insights from natural torpor

  2025cites this paper
• Alzheimer’s disease basics: we all should know

  2025cites this paper
• Protein kinase CK2α’ as a dual modulator of immune signaling and synaptic dysfunction in Tauopathy

  2025cites this paper
• Early signs of neuron autonomous and non‐autonomous hyperexcitability in locus coeruleus noradrenergic neurons of a mouse model of tauopathy and Alzheimer's disease

  2025cites this paper
• Loss of excitatory inputs and decreased tonic and evoked activity of locus coeruleus neurons in aged P301S mice

  2025cites this paper
• Dysregulated cortical excitability and tau phosphorylation in a β3 integrin mouse model of autism

  2025cites this paper
• Autophagy in alzheimer disease pathogenesis and its therapeutic values

  2025cites this paper
• The Unified Theory of Neurodegeneration Pathogenesis Based on Axon Deamidation

  2025cites this paper
• The Role of the Progesterone Receptor Family in Alzheimer’s Disease

  2025cites this paper
• PRMT3‐Mediated H4R3me2a Promotes Primary Age‐Related Tauopathy by Driving Tau Hyperphosphorylation in Neuron

  2025cites this paper
• Are we missing a trick by not exploiting fruit flies in inflammation-led drug discovery for neurodegeneration?

  2025cites this paper
• Systematic Review and Network Meta-Analysis of Retinal Imaging Biomarkers in Neurodegenerative Diseases: Correlation with Brain Changes.

  2025cites this paper
• Chuanxiong-Danggui herb pair alleviated cognitive deficits of APP/PS1 mice by promoting mitophagy.

  2025cites this paper
• SORLA upregulation suppresses global pathological effects in aged tauopathy mouse brain

  2025cites this paper
• Synaptic loss pattern is constrained by brain connectome and modulated by phosphorylated tau in Alzheimer’s disease

  2025cites this paper
• Glial phagocytosis for synapse and toxic proteins in neurodegenerative diseases

  2025cites this paper
• Decoding tau acetylation in Alzheimer’s disease and tauopathies: from site-specific mechanisms to therapeutic horizons

  2025cites this paper
• Ceftriaxone ameliorates tau phosphorylation and mislocalization in APP/PS1 AD mice by inhibiting endoplasmic reticulum stress.

  2025cites this paper
• Axonal tau reduction ameliorates tau and amyloid pathology in a mouse model of Alzheimer’s disease

  2025cites this paper
• Correlation of β2-microglobulin with postoperative delirium and 3-year mortality undergoing knee or hip replacement surgery: a prospective cohort study

  2025cites this paper
• Protein kinase CK2α’ as a dual modulator of neuroimmune signaling and synaptic dysfunction in Tauopathy

  2025cites this paper
• Concussive injuries induce neuronal stress-dependent tau mislocalization to dendritic spines with acrolein and functional network alteration in TBI-on-a-chip

  2025cites this paper
• ApoE-calypse tau: ApoE-tau synergy in Alzheimer's disease.

  2025cites this paper
• Reduced synaptic vesicle protein 2A in extracellular vesicles and brains of Alzheimer’s disease: associations with Aβ, tau, synaptic proteins and APOE ε4

  2025cites this paper
• The medial septum-hippocampus-lateral septum circuitry in spatial memory: linking healthy function to early Alzheimer’s disease and translational opportunities

  2025cites this paper
• Advances of therapeutic strategies for Alzheimer’s disease

  2025cites this paper
• Stabilizing microtubules increases acute cellular injury at high strain rates.

  2025cites this paper
• Pathogenic tau inhibits synaptic plasticity by blocking eIF4B-mediated local protein synthesis

  2025cites this paper
• Tau post-translational modifications in Alzheimer's disease: insights into pathogenesis, therapeutic strategies, and diagnostic advances

  2025cites this paper
• CSF total tau as a proxy of synaptic degeneration

  2025cites this paper
• Intra-axonal Nanomagnetic Forces Differentially Impact hTau40 Transport Dynamics in Primary Cortical and Hippocampal Neurons.

  2025cites this paper
• The association of the Wnt/β-catenin signaling pathway with Alzheimer's disease.

  2025cites this paper
• Graded regulation of microtubule-binding of Tau by the phosphorylation state of the proline-rich region in living neurons.

  2025cites this paper
• Synaptic vulnerability to amyloid-β and tau pathologies differentially disrupts emotional and memory neural circuits

  2025cites this paper
• Large-scale seroepidemiology uncovers nephro-urological pathologies in people with tau autoimmunity

  2025cites this paper
• The Role of Oligodendrocyte Lineage Cells in the Pathogenesis of Alzheimer’s Disease

  2025cites this paper
• Loss of excitatory inputs and decreased tonic and evoked activity of locus coeruleus neurons in aged P301S mice

  2025cites this paper
• Phytochemicals in Neurological Disorders Management: A Comprehensive Review

  2025cites this paper
• Parkinson's Disease and Mitotherapy-Based Approaches towards α-Synucleinopathies.

  2024cites this paper
• Exploring the role of underrepresented populations in polygenic risk scores for neurodegenerative disease risk prediction

  2024cites this paper
• Dual Role of NMDAR Containing NR2A and NR2B Subunits in Alzheimer’s Disease

  2024cites this paper
• STAU1 exhibits a dual function by promoting amyloidogenesis and tau phosphorylation in cultured cells.

  2024cites this paper
• Neuronal hypofunction and network dysfunction in a mouse model at an early stage of tauopathy

  2024cites this paper
• Aβ peptide enhances GluA1 internalization via lipid rafts in Alzheimer's-related hippocampal LTP dysfunction.

  2024cites this paper
• The Current Landscape in the Development of Small-molecule Modulators Targeting Sphingosine-1-phosphate Receptors to Treat Neurodegenerative Diseases.

  2024cites this paper
• G272V and P301L Mutations Induce Isoform Specific Tau Mislocalization to Dendritic Spines and Synaptic Dysfunctions in Cellular Models of 3R and 4R Tau Frontotemporal Dementia

  2024cites this paper
• Tau pathology is associated with synaptic density and longitudinal synaptic loss in Alzheimer’s disease

  2024cites this paper
• The six brain‐specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes

  2024cites this paper
• Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology.

  2024cites this paper
• Phytochemical Screening of Asparagus racemosus Willd

  2024cites this paper
• Synaptic alterations associated with disrupted sensory encoding in a mouse model of tauopathy

  2024cites this paper